An open clinical trial to determine the efficacy of Manjitti kudineer and Manjitti nei in the chronic non healing ulcers,burns and scalds

An open clinical trial to determine the efficacy of Manjitti kudineer (internal) and Manjitti nei (external)in the treatment of Viranam-chronic non healing ulcers,burns and scalds

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2015/01/005439

Enrollment

Registered

2015-01-21

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- non healing ulcers

Interventions

Intervention1: manjitti kudineer manjitti nei: manjitti kudineer 60ml bd for 45days manjitti nei for external application Control Intervention1: nil: nil Control Intervention2: nil: nil

Eligibility

Inclusion criteria

Inclusion criteria: ï?· Patients who are admitted with the complaints of Non Healing cutaneous ulcer of 3 months or more duration ï?· Ulcers sustained due to burns and scalds of any duration with area less than 10 percentage

Exclusion criteria

Exclusion criteria: Vulnerable groups ï?· Syphilitic, Lepromatous and Tuberculous ulcers ï?· Patients with severe neurological damage or arterial obstruction characterized by profound Anaesthesia and deep excruciatingly painful ulcers involving the muscles. ï?· Patients with complications of severe pyogenic infections indicated by copious discharge ï?· Patients with severe destruction to the tissue architecture.

Design outcomes

Primary

Measure	Time frame
healing of chronic woundsTimepoint: 25 days	—

Secondary

Measure	Time frame
establishment of safety of the test drug internal administrationTimepoint: 15 days	—

Countries

India

Contacts

Public ContactDR G J CHRISTIAN

National Institute of Siddha

christianvijila@gmail.com9962545930

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026